Business Description
Anixa Biosciences Inc (Anixa) is a cancer-based biotechnology company. It involves in the development of patented technologies in the areas of oncology and infectious disease. The company focuses on the research of immuno-oncology and enables the development of revolutionary immunotherapies for treating certain cancer types. Its vaccine portfolio includes a technology aimed at the immunization against retired proteins for trating breast cancer, primarily the triple negative breast cancer and ovarian cancer. Its key therapeutics portfolio comprises a cancer immunotherapy program, which uses a novel type of CAR-T, a chimeric endocrine receptor T-cell (CER-T) technology and also COVID-19 therapeutics program, which is focused on inhibiting viral protein function.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer